HCM
LJPC

Highbridge Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Highbridge Capital Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-34,374
Closed -$818K – 1870
2016
Q3 		$818K Buy
+34,374
New +$648K 0.01% 626
2015
Q4 		– Sell
-9,011
Closed -$251K – 2125
2015
Q3 		$251K Buy
+9,011
New +$284K ﹤0.01% 1296
2014
Q4 		– Sell
-11,389
Closed -$110K – 1706
2014
Q3 		$110K Buy
+11,389
New +$113K ﹤0.01% 1144

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Highbridge Capital Management's LJPC Position: Q4 2016 in Review

Highbridge Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2016, closing a stake of 34,374 shares — an estimated $818K sold.

Highbridge Capital Management first reported a position in LJPC in Q3 2014 and held it in 3 quarters. The position peaked at $818K in Q3 2016. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

  • Highbridge Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q4 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 34,374 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $818K.
  • Highbridge Capital Management first reported a position in La Jolla Pharmaceutical Company in Q3 2014 and held it in 3 quarters.
  • Highbridge Capital Management's La Jolla Pharmaceutical Company position peaked at $818K in Q3 2016.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.